Roles of Identified Long Noncoding RNA in Diabetic Nephropathy

by Yan Li, Keyang Xu, Kechen Xu, Sixiang Chen, Yifang Cao, Huakui Zhan
Published 2019-01-01

RNA N6-methyladenosine: a promising molecular target in metabolic diseases

by Yan Li, Jiawen Wang, Chunyan Huang, Meng Shen, Huakui Zhan, Keyang Xu
Published 2020-02-01

Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study

by Keyang Xu, Xu Zhao, Xiaoqing Fu, Kechen Xu, Zhaoyi Li, Liangbin Miao, Yan Li, Zhaobin Cai, Liang Qiao, Jianfeng Bao
Published 2019-09-01

Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy

by Yan Li, Lei Wang, Bojun Xu, Liangbin Zhao, Li Li, Keyang Xu, Anqi Tang, Shasha Zhou, Lu Song, Xiao Zhang, Huakui Zhan
Published 2021-01-01

Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism

by Xianjing Hu, Sarwat Fatima, Minting Chen, Keyang Xu, Chunhua Huang, Rui-Hong Gong, Tao Su, Hoi Leong Xavier Wong, Zhaoxiang Bian, Hiu Yee Kwan
Published 2021-08-01

Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol

by Keyang Xu, Shourong Liu, Xu Zhao, Xiantu Zhang, Xiaoqing Fu, Yumei Zhou, Kechen Xu, Liangbin Miao, Zhaoyi Li, Yan Li, Liang Qiao, Jianfeng Bao
Published 2019-02-01

Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis

by Bojun Xu, Lei Wang, Huakui Zhan, Liangbin Zhao, Yuehan Wang, Meng Shen, Keyang Xu, Li Li, Xu Luo, Shasha Zhou, Anqi Tang, Gang Liu, Lu Song, Yan Li
Published 2021-01-01